Hongene Biotech Corporation and ReciBioPharm Establish a Gene Editing Development Partnership
0800 AM Eastern on Monday 9th September – Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, have announced a strategic...